| Revenue | NOK 700K | -22% |
| EBITDA | NOK 48K | -80% |
| Net profit | NOK -8K | -106% |
| Total assets | NOK 408K | -18% |
| Equity | NOK 389K | -2% |
| Employees | 1 | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 593 | 812 | 748 | 694 | 812 | 1 027 | 1 024 | 900 | 700 |
| Staff expenses | −0 | −0 | −79 | −150 | −154 | −71 | −29 | −38 | −29 | −22 |
| EBITDA | 0 | 177 | 292 | 138 | 89 | 197 | 452 | 288 | 235 | 48 |
| Depreciation & amort. | −0 | −80 | −112 | −119 | −56 | −34 | −22 | −49 | −60 | −56 |
| EBIT | 0 | 97 | 180 | 19 | 33 | 163 | 430 | 239 | 175 | −8 |
| Net financials | 0 | −21 | −17 | −14 | −10 | −6 | −0 | 1 | 1 | −0 |
| Profit before tax | 0 | 76 | 163 | 5 | 23 | 157 | 430 | 240 | 176 | −8 |
| Tax | −0 | 17 | 47 | 15 | 6 | 31 | 93 | 47 | 38 | −0 |
| Net profit | 0 | 59 | 116 | −10 | 17 | 126 | 336 | 193 | 137 | −8 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 30 | 555 | 558 | 352 | 295 | 339 | 605 | 417 | 499 | 408 |
| Equity | 23 | 82 | 107 | 97 | 114 | 150 | 157 | 260 | 397 | 389 |
| Long-term debt | 0 | 364 | 286 | 204 | 139 | 48 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 | 110 | 164 | 50 | 42 | 141 | 448 | 158 | 102 | 19 |
| Total debt | 7 | 474 | 450 | 254 | 181 | 189 | 448 | 158 | 102 | 19 |
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Trysil Fysioterapi As | Company | 66.0% | 66.0% | 2022 |
| Person | Role here | Other companies |
|---|---|---|
| Anders Mejlbo | Board of Directors | 0 companies |
| Merethe Bekkvang | Chairman | 0 companies |
| Stian Dypflod | Board of Directors | 0 companies |